Cargando…
COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey
Vaccine hesitancy (VH) is a major health threat to the efforts to tackle COVID-19 morbidity and mortality. This study’s objectives were to assess COVID-19 VH before and after vaccines' availability and to analyze the associations between COVID-19 VH and participants’ characteristics. A national...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472961/ https://www.ncbi.nlm.nih.gov/pubmed/36137905 http://dx.doi.org/10.1016/j.vaccine.2022.08.070 |
_version_ | 1784789403074297856 |
---|---|
author | Frankenthal, Dvora Zatlawi, Miri Karni-Efrati, Ziv Keinan-Boker, Lital Luxenburg, Osnat Bromberg, Michal |
author_facet | Frankenthal, Dvora Zatlawi, Miri Karni-Efrati, Ziv Keinan-Boker, Lital Luxenburg, Osnat Bromberg, Michal |
author_sort | Frankenthal, Dvora |
collection | PubMed |
description | Vaccine hesitancy (VH) is a major health threat to the efforts to tackle COVID-19 morbidity and mortality. This study’s objectives were to assess COVID-19 VH before and after vaccines' availability and to analyze the associations between COVID-19 VH and participants’ characteristics. A national cross-sectional telephone interview survey among Israeli adults aged 21 and older was conducted from September 2020 through May 2021. Attitudes towards COVID-19 vaccines were assessed pre/post vaccines' availability. Multivariate logistic regression analyses were used to identify associations between demographic and health-related characteristics and COVID-19 VH. Most study participants (72.0 % of 2,998) were willing to be vaccinated against COVID-19 across the survey period. The COVID-19 VH declined significantly from 45.6 % pre-vaccine availability to 16.3 % post-vaccine availability (P < 0.001). The multivariable analysis demonstrated that post-vaccine availability, COVID-19 VH was associated with younger age, Arab ethnicity, higher level of religiosity, lower education, past diagnosis of COVID-19, and influenza VH. The main reasons for VH after the vaccine availability included insufficient data on the vaccine (37.4 %) and fear of the vaccine's side effects (33.8 %). Despite the significant decrease in COVID-19 VH following vaccine availability, 16.3% of the population still refuses to get vaccinated. As Israel may face additional waves of the COVID-19 pandemic and booster vaccinations, multimedia vaccine promotions targeting the above-mentioned hesitant populations and their reasons for VH are urgently needed. |
format | Online Article Text |
id | pubmed-9472961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94729612022-09-15 COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey Frankenthal, Dvora Zatlawi, Miri Karni-Efrati, Ziv Keinan-Boker, Lital Luxenburg, Osnat Bromberg, Michal Vaccine Article Vaccine hesitancy (VH) is a major health threat to the efforts to tackle COVID-19 morbidity and mortality. This study’s objectives were to assess COVID-19 VH before and after vaccines' availability and to analyze the associations between COVID-19 VH and participants’ characteristics. A national cross-sectional telephone interview survey among Israeli adults aged 21 and older was conducted from September 2020 through May 2021. Attitudes towards COVID-19 vaccines were assessed pre/post vaccines' availability. Multivariate logistic regression analyses were used to identify associations between demographic and health-related characteristics and COVID-19 VH. Most study participants (72.0 % of 2,998) were willing to be vaccinated against COVID-19 across the survey period. The COVID-19 VH declined significantly from 45.6 % pre-vaccine availability to 16.3 % post-vaccine availability (P < 0.001). The multivariable analysis demonstrated that post-vaccine availability, COVID-19 VH was associated with younger age, Arab ethnicity, higher level of religiosity, lower education, past diagnosis of COVID-19, and influenza VH. The main reasons for VH after the vaccine availability included insufficient data on the vaccine (37.4 %) and fear of the vaccine's side effects (33.8 %). Despite the significant decrease in COVID-19 VH following vaccine availability, 16.3% of the population still refuses to get vaccinated. As Israel may face additional waves of the COVID-19 pandemic and booster vaccinations, multimedia vaccine promotions targeting the above-mentioned hesitant populations and their reasons for VH are urgently needed. Elsevier Ltd. 2022-10-12 2022-09-14 /pmc/articles/PMC9472961/ /pubmed/36137905 http://dx.doi.org/10.1016/j.vaccine.2022.08.070 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Frankenthal, Dvora Zatlawi, Miri Karni-Efrati, Ziv Keinan-Boker, Lital Luxenburg, Osnat Bromberg, Michal COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey |
title | COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey |
title_full | COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey |
title_fullStr | COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey |
title_full_unstemmed | COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey |
title_short | COVID-19 vaccine hesitancy among Israeli adults before and after vaccines’ availability: A cross-sectional national survey |
title_sort | covid-19 vaccine hesitancy among israeli adults before and after vaccines’ availability: a cross-sectional national survey |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472961/ https://www.ncbi.nlm.nih.gov/pubmed/36137905 http://dx.doi.org/10.1016/j.vaccine.2022.08.070 |
work_keys_str_mv | AT frankenthaldvora covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey AT zatlawimiri covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey AT karniefratiziv covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey AT keinanbokerlital covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey AT luxenburgosnat covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey AT brombergmichal covid19vaccinehesitancyamongisraeliadultsbeforeandaftervaccinesavailabilityacrosssectionalnationalsurvey |